Acetyl-L-carnitine improves cognitive functions in severe hepatic encephalopathy: A randomized and controlled clinical trial

Metabolic Brain Disease

Volumn 26, Issue 4, 2011, Pages 281-289

  Malaguarnera, Michele ^a   Vacante, Marco ^a   Motta, Massimo ^a   Giordano, Maria ^a   Malaguarnera, Giulia ^a   Bella, Rita ^a   Nunnari, Giuseppe ^a   Rampello, Liborio ^a   Pennisi, Giovanni ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Acetyl L carnitine; Cognitive functions; L carnitine; Severe hepatic encephalopathy

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIA; LEVACECARNINE; PLACEBO; PROTHROMBIN;

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL ASSESSMENT; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEMORY; PERSONALITY TEST; PROTHROMBIN TIME; PSYCHOLOGIC TEST; PSYCHOMETRY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; TREATMENT OUTCOME;

ACETYLCARNITINE; ADULT; ALANINE TRANSAMINASE; AMMONIA; BILIRUBIN; COGNITION; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; INTELLIGENCE TESTS; MALE; MIDDLE AGED; NOOTROPIC AGENTS; PROTHROMBIN TIME; QUESTIONNAIRES; SERUM ALBUMIN; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 83655192001     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-011-9260-z     Document Type: Article

References (52)

1. MF Beal 1993 Neurochemical aspects of aging in primates Neurobiol Aging 14 707 709 10.1016/0197-4580(93)90080-U 7905191 10.1016/0197-4580(93)90080-U 1:CAS:528:DyaK2cXhs1Sju7c%3D (Pubitemid 23347929)
2. M Bélanger P Desjardins N Chatauret RF Butterworth 2002 Loss of expression of glial fibrillary acidic protein in acute hyperammonemia Neurochem Int 41 155 160 10.1016/S0197-0186(02)00037-2 12020615 10.1016/S0197-0186(02) 00037-2 (Pubitemid 34521688)
3. AL Benton 1994 Neuropsychological assessment Annu Rev Psychol 45 1 23 10.1146/annurev.ps.45.020194.000245 8135502 10.1146/annurev.ps.45.020194.000245 1:STN:280:DyaK2c7ot12jsw%3D%3D
4. ZK Binienda 2003 Neuroprotective effects of L-carnitine in induced mitochondrial dysfunction Ann N Y Acad Sci 993 289 295 10.1111/j.1749-6632.2003. tb07536.x 12853320 10.1111/j.1749-6632.2003.tb07536.x 1:CAS:528: DC%2BD3sXmtVajsL4%3D (Pubitemid 36808457)
5. J Bremer 1983 Carnitine-metabolism and functions Physiol Rev 63 1420 1480 6361812 1:CAS:528:DyaL2cXmsFGgsQ%3D%3D PMid:6361812
6. JO Brooks 3rd JA Yesavage A Carta D Bravi 1998 Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach Int Psychogeriatr 10 193 203 10.1017/S1041610298005304 9677506 10.1017/ S1041610298005304 (Pubitemid 28375550)
7. RF Butterworth 2001 Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings Metab Brain Dis 16 55 65 10.1023/A:1011614528751 11726089 10.1023/A:1011614528751 1:CAS:528: DC%2BD3MXpt1Wnt7Y%3D (Pubitemid 33064037)
8. RF Butterworth 2002 Pathophysiology of hepatic encephalopathy: a new look at ammonia Metab Brain Dis 17 221 227 10.1023/A:1021989230535 12602499 10.1023/A:1021989230535 1:CAS:528:DC%2BD3sXislGksQ%3D%3D (Pubitemid 36204752)
9. RF Butterworth JF Giguère J Michaud J Lavoie GP Layrargues 1987 Ammonia: key factor in the pathogenesis of hepatic encephalopathy Neurochem Pathol 6 1 12 10.1007/BF02833598 3306479 10.1007/BF02833598 1:STN:280: DyaL2szhs1SrsA%3D%3D
10. F Da Fonseca-Wollheim 1973 Direkte plasmaammoniakbestimmung ohne Enteiweissung Z Klin Chem Biochem 11 426 431
11. P Desjardins KG Todd AS Hazell RF Butterworth 1999 Increased "peripheral-type" benzodiazepine receptor sites and mRNA in thalamus of thiamine-deficient rats Neurochem Int 35 363 369 10.1016/S0197-0186(99)00082- 0 10517697 10.1016/S0197-0186(99)00082-0 1:CAS:528:DyaK1MXms1Wqtbw%3D (Pubitemid 29397663)
12. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2486 2497 10.1001/jama.285.19.2486 10.1001/jama.285.19.2486
13. V Felipo MD Miñana H Cabedo S Grisolía 1994 L-carnitine increases the affinity of glutamate for quisqualate receptors and prevents glutamate neurotoxicity Neurochem Res 19 373 377 10.1007/BF00971588 7909920 10.1007/BF00971588 1:CAS:528:DyaK2cXhsFCmt7Y%3D (Pubitemid 24054810)
14. V Felipo C Hermenegildo C Montoliu M Llansola MD Miñana 1998 Neurotoxicity of ammonia and glutamate: molecular mechanisms and prevention Neurotoxicology 19 675 681 9745928 1:CAS:528:DyaK1cXlvVCnu7Y%3D PMid:9745928
15. JL Flanagan PA Simmons J Vehige MD Willcox Q Garrett 2010 Role of carnitine in disease Nutr Metab (Lond) 7 30 10.1186/1743-7075-7-30 10.1186/1743-7075-7-30
16. MF Folstein SE Folstein PR McHugh 1975 "Mini Mental State". A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 10.1016/0022-3956(75)90026-6 1202204 10.1016/0022-3956(75)90026-6 1:STN:280:DyaE28%2FntFKjtw%3D%3D
17. GM Franklin RK Heaton LM Nelson CM Filley C Seibert 1988 Correlation of neuropsychological and MRI findings in chronic/progressive multiple sclerosis Neurology 38 1826 1829 3194059 1:STN:280:DyaL1M%2FlslagtA%3D%3D PMid:3194059 (Pubitemid 19004572)
18. JB Gregorios LW Mozes MD Norenberg 1985 Morphologic effects of ammonia on primary astrocyte cultures. II. Electron microscopic studies J Neuropathol Exp Neurol 44 404 414 10.1097/00005072-198507000-00004 4040156 10.1097/00005072- 198507000-00004 1:STN:280:DyaL2M3js1Citg%3D%3D (Pubitemid 15058442)
19. TM Hagen J Liu J Lykkesfeldt CM Wehr RT Ingersoll V Vinarsky JC Bartholomew BN Ames 2002 Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress Proc Natl Acad Sci U S A 99 1870 1875 10.1073/pnas.261708898 11854487 10.1073/pnas.261708898 1:CAS:528:DC%2BD38XitVSrsro%3D (Pubitemid 34168981)
20. Harper C, Butterworth RF (1997) Nutritional and metabolic disorders. In: Lantos P, Graham D (eds) Greenfield's neuropathology, 6th edn. Edward Arnold, Cambridge, pp 601-655
21. D Häussinger F Schliess 2008 Pathogenetic mechanisms of hepatic encephalopathy Gut 57 1156 1165 10.1136/gut.2007.122176 18628377 10.1136/gut.2007.122176
22. D Häussinger G Kircheis R Fischer F Schliess S vom Dahl 2000 Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema? J Hepatol 32 1035 1038 10.1016/S0168-8278(00)80110-5 10898326 10.1016/S0168-8278(00)80110-5 (Pubitemid 30368099)
23. D Hinerfeld MD Traini RP Weinberger B Cochran SR Doctrow J Harry S Melov 2004 Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice J Neurochem 88 657 667 10.1046/j.1471-4159.2003.02195.x 14720215 10.1046/j.1471-4159.2003.02195.x 1:CAS:528:DC%2BD2cXhtVaitrY%3D (Pubitemid 38140210)
24. Hooper HE (1983) Hooper visual organization test. WPS
25. R Jover R Rodrigo V Felipo R Insausti J Sáez-Valero MS García-Ayllón I Suárez A Candela A Compañ A Esteban O Cauli E Ausó E Rodríguez A Gutiérrez E Girona S Erceg P Berbel M Pérez-Mateo 2006 Brain edema and inflammatory activation in bile duct ligated rats with diet-induced hyperammonemia: a model of hepatic encephalopathy in cirrhosis Hepatology 43 1257 1266 10.1002/hep. 21180 16729306 10.1002/hep.21180 1:CAS:528:DC%2BD28XmsF2ntbw%3D (Pubitemid 43980104)
26. Malaguarnera M, Pistone G, Astuto M, Dell'Arte S, Finocchiaro G, Lo Giudice E, Pennisi G (2003) L-Carnitine in the treatment of mild or moderate hepatic encephalopathy. Dig Dis 21(3):271-275. doi: 10.1159/000073347 PMid:14571103 (Pubitemid 37323484)
27. M Malaguarnera G Pistone R Elvira C Leotta L Scarpello R Liborio 2005 Effects of L-carnitine in patients with hepatic encephalopathy World J Gastroenterol 11 45 7197 7202 16437672 1:CAS:528:DC%2BD28Xhs1Kltrk%3D (Pubitemid 43154020)
28. M Malaguarnera G Pistone M Astuto I Vecchio R Raffaele E Lo Giudice L Rampello 2006 Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial Dig Dis Sci 51 2242 2247 10.1007/s10620-006-9187-0 17080254 10.1007/s10620-006-9187-0 1:CAS:528:DC%2BD2sXktFCksg%3D%3D PMid:17080254
29. M Malaguarnera L Cammalleri MP Gargante M Vacante V Colonna M Motta 2007 L-Carnitine treatment reduces severity of physical and mental fatigue and increases cognitive functions in centenarians: a randomized and controlled clinical trial Am J Clin Nutr 86 6 1738 1744 18065594 1:CAS:528: DC%2BD2sXhsVGhsL%2FI (Pubitemid 350232191)
30. M Malaguarnera MP Gargante E Cristaldi M Vacante C Risino L Cammalleri G Pennisi L Rampello 2008 Acetyl-L-carnitine treatment in minimal hepatic encephalopathy Dig Dis Sci 53 3018 3025 10.1007/s10620-008-0238-6 18357530 10.1007/s10620-008-0238-6 1:CAS:528:DC%2BD1cXht1ChsbbO
31. Malaguarnera M, Bella R, Vacante M, Giordano M, Malaguarnera G, Gargante MP, Motta M, Mistretta A, Rampello L, Pennisi G (2011a) Acetyl-L-carnitine reduces depression and improves quality of life in patients with minimal hepatic encephalopathy. Scand J Gastroenterol 46(6):750-759. doi: 10.3109/00365521. 2011.565067 PMid:21443422
32. Malaguarnera M, Vacante M, Giordano M, Pennisi G, Bella R, Rampello L, Malaguarnera M, Li Volti G, Galvano F (2011b) Oral acetyl-L-carnitine therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Am J Clin Nutr 93(4):799-808. doi: 10.3945/ajcn.110.007393 PMid:21310833
33. M Matsuoka H Igisu 1993 Comparison of the effects of L-carnitine, D-carnitine and acetyl-L-carnitine on the neurotoxicity of ammonia Biochem Pharmacol 46 159 164 10.1016/0006-2952(93)90360-9 8347126 10.1016/0006-2952(93) 90360-9 1:CAS:528:DyaK3sXlvFGlsb0%3D (Pubitemid 23218594)
34. SA Montgomery LJ Thal R Amrein 2003 Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease Int Clin Psychopharmacol 18 61 71 10.1097/00004850-200303000-00001 12598816 10.1097/00004850-200303000-00001 (Pubitemid 36343974)
35. JT Neary LO Norenberg MP Gutierrez MD Norenberg 1987 Hyperammonemia causes altered protein phosphorylation in astrocytes Brain Res 437 161 164 10.1016/0006-8993(87)91538-1 2827864 10.1016/0006-8993(87)91538-1 1:CAS:528:DyaL1cXltV2isQ%3D%3D (Pubitemid 18029700)
36. G Peluso A Barbarisi V Savica E Reda R Nicolai P Benatti M Calvani 2000 Carnitine: an osmolyte that plays a metabolic role J Cell Biochem 80 1 10 10.1002/1097-4644(20010101)80:1<1::AID-JCB10>3.0.CO;2-W 11029749 10.1002/1097-4644(20010101)80:1<1::AID-JCB10>3.0.CO;2-W 1:CAS:528:DC%2BD3cXot1Gmu7k%3D (Pubitemid 32378178)
37. JW Pettegrew J Levine RJ McClure 2000 Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression Mol Psychiatry 5 616 632 10.1038/sj.mp.4000805 11126392 10.1038/sj.mp.4000805 1:CAS:528: DC%2BD3cXosFSgs74%3D
38. MJ Poveda A Bernabeu L Concepción E Roa E de Madaria P Zapater M Pérez-Mateo R Jover 2010 Brain edema dynamics in patients with overt hepatic encephalopathy A magnetic resonance imaging study NeuroImage 52 481 487 10.1016/j.neuroimage.2010.04.260 20451628 10.1016/j.neuroimage.2010.04.260
39. RN Pugh IM Murray-Lyon JL Dawson MC Petroni R Williams 1973 Transection of the oesophagus for bleeding oesophageal varices Br J Surg 60 646 649 10.1002/bjs.1800600817 4541913 10.1002/bjs.1800600817 1:STN:280: DyaE3s3jsVWqsw%3D%3D
40. K Qureshi KV Rao IA Qureshi 1998 Differential inhibition by hyperammonemia of the electron transport chain enzymes in synaptosomes and non-synaptic mitochondria in ornithine transcarbamylase-deficient spf-mice: restoration by acetyl-L-carnitine Neurochem Res 23 855 861 10.1023/A: 1022406911604 9572674 10.1023/A:1022406911604 1:CAS:528:DyaK1cXisVCqtLs%3D (Pubitemid 28178158)
41. KV Rao YR Mawal IA Qureshi 1997 Progressive decrease of cerebral cytochrome C oxidase activity in sparse-fur mice: role of acetyl-L-carnitine in restoring the ammonia-induced cerebral energy depletion Neurosci Lett 224 83 86 10.1016/S0304-3940(97)13476-0 9086462 10.1016/S0304-3940(97)13476-0 1:CAS:528:DyaK2sXhvFWntLk%3D (Pubitemid 27122176)
42. L Ratnakumari IA Qureshi RF Butterworth 1993 Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy Metabolism 42 1039 1046 10.1016/0026-0495(93)90020-O 8102193 10.1016/0026-0495(93)90020-O 1:CAS:528:DyaK3sXltFKit74%3D (Pubitemid 23230438)
43. Reitan RM, Wolfson D (1993) The Halstead-Reitan: neuropsychological test battery: theory and clinical interpretation. Neuropsychology Press, Tucson
44. A Spagnoli U Lucca G Menasce L Bandera G Cizza G Forloni M Tettamanti L Frattura P Tiraboschi M Comelli, et al. 1991 Long-term acetyl-L-carnitine treatment in Alzheimer's disease Neurology 41 1726 1732 1944900 1:STN:280:DyaK38%2FltVahsg%3D%3D
45. A Sunderland JE Harris AD Baddeley 1983 Do laboratory tests predict A neuropsychological study J Verbal Learning Verbal Behav 22 341 357 10.1016/S0022-5371(83)90229-3 10.1016/S0022-5371(83)90229-3
46. LJ Thal M Calvani A Amato A Carta 2000 A 1-year controlled trial of acetyl-l-carnitine in early-onset AD Neurology 55 805 810 10994000 1:CAS:528:DC%2BD3cXntlygsb8%3D
47. C Van Der Rijt SW Schalm 1985 Quantitative EEG analysis and survival in liver disease Electroencephalogr Clin Neurophysiol 61 502 504 10.1016/0013-4694(85)90968-X 2415324 10.1016/0013-4694(85)90968-X (Pubitemid 16212563)
48. A Virmani Z Binienda 2004 Role of carnitine esters in brain neuropathology Mol Aspects Med 25 533 549 10.1016/j.mam.2004.06.003 15363640 10.1016/j.mam.2004.06.003 1:CAS:528:DC%2BD2cXnsVyrurc%3D (Pubitemid 39195075)
49. Voigt M, Conn H (1995) Hepatic encephalopathy. In: Robson SC, Trey C, Kirsch RE (eds) Diagnosis and management of liver disease. Chapman & Hall, London, pp 140-147, Chapter 13
50. D Wechsler 1945 A standardized Memory Scale for Clinical use J Psychol 87 95
51. World Medical Association Declaration of Helsinki 1997 Recommendations guiding physicians in biomedical research involving human subjects JAMA 277 925 926 10.1001/jama.277.11.925 10.1001/jama.277.11.925
52. G Wright R Jalan 2007 Ammonia and inflammation in the pathogenesis of hepatic encephalopathy: Pandora's box? Hepatology 46 291 294 10.1002/hep. 21843 17661413 10.1002/hep.21843 1:CAS:528:DC%2BD2sXhtVSisb7O (Pubitemid 47344761)